May 12, 2025, 20:14

Cancer Grand Challenge: The Dark Proteome

This challenge invites global research teams to uncover the origins, functions, and therapeutic potential of the “dark proteome”—a group of proteins not derived from known coding sequences or DNA mutations. By understanding these unconventional proteins, the challenge aims to reveal new cancer vulnerabilities and develop immunologic or small molecule therapies that can be applied broadly across tumour types.

Eligibility Criteria:

Global, interdisciplinary research teams
Expertise in proteomics, immunology, RNA/protein biology, oncology, genetics, and analytical chemistry
Proposals must focus on proteins, not non-coding RNAs or splicing alterations

Funding Details:

Up to £20 million (USD 25 million) per team
Duration: Not specified

Deadline:

Expressions of Interest due: 18 June 2025

More Information:

Submit your Expression of Interest

cancer cancer biology Cancer Grand Challenge dark proteome immunotherapy microproteins novel antigens OncoDaily Oncology protein expression proteogenomics Synthetic Lethality tumour-selective targets

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Writer?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...